The COVID-19 Pandemic – News and Features

Researchers identified more than 200 new vaccine target candidates from SARS-CoV-2, focusing on seven viral proteins beyond the Spike protein. These candidates could enhance immunity by triggering T cell responses.

David Baker, Demis Hassabis and John Jumper have been awarded the 2024 Nobel Prize for Chemistry for their work on computational protein design and protein structure prediction.

A recent study found that people with any type of COVID-19 infection were twice as likely to have a major cardiac event, such as heart attack, stroke or even death, for up to three years after diagnosis.

Researchers have engineered an enzyme to produce synthetic genetic material, advancing the discovery of new therapeutics for cancer and autoimmune, metabolic and infectious diseases.

A study found long-term microstructural abnormalities in the brainstem of COVID-19 survivors, suggesting neuroinflammation contributes to persistent symptoms like fatigue and brain fog.

This article explores the revolution in new drug modalities and the challenges around effective data strategies to support AI efforts.

Researchers discovered that recall germinal centers, activated upon re-exposure to pathogens, draw on naive B cells to create new antibodies while experienced B cells respond immediately.

A new study has revealed subtle differences in memory and cognition in patients infected with SARS-CoV-2.

A trial found low doses of lithium aspartate ineffective for long COVID-related fatigue and brain fog. However, a supplemental study indicated higher doses might help.

Recovery from COVID-19 infection can have a protective effect against the worst effects of flu, and this memory response comes from an unexpected corner of the immune system.